Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorth Atl.smlr Regulatory News (NAS)

Share Price Information for North Atl.smlr (NAS)

Share Price is delayed by 15 minutes
Get Live Data
394.00    0.00 (0.00%)
Bid:
391.00
Ask:
399.00
Spread: 8.00 (2.046%)
Market Cap: £501.01m
NAS Live PriceLast checked at - London Stock Exchange

Intraday North Atl.smlr Share Chart

Holding(s) in Company

2 Nov 2015 10:38

RNS Number : 1827E
Source BioScience PLC
02 November 2015
 



TR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES i

 

1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached: ii

SOURCE BIOSCIENCE PLC

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

YES

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

An event changing the breakdown of voting rights

Other (please specify):

 

3. Full name of person(s) subject to the notification obligation: iii

 

Harwood Capital LLP (as investment adviser/manager) and North Atlantic Smaller Companies Investment Trust plc

4. Full name of shareholder(s)

(if different from 3.): iv

 

1. NORTH ATLANTIC SMALLER COMPANIES INVESTMENT TRUST PLC

 

2. ORYX INTERNATIONAL GROWTH FUND LIMITED

 

 

5. Date of the transaction and date on which the threshold is crossed or reached: v

29 OCTOBER 2015

6. Date on which issuer notified:

30 OCTOBER 2015

7. Threshold(s) that is/are crossed or

reached: vi, vii

 

 

Total Holding through 15%

 

 

 

 

 

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

HOLDER 1

 

HOLDER 2

 

 1,500,000

 

50,000,000

 

1,500,000

 

50,000,000

 

2,750,000

 

50,000,000

 

 2,750,000

 

50,000,000

 

 

0.79%

 

14.32%

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/ConversionPeriod xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

 

% of votingrights

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exerciseprice

Expirationdate xvii

Exercise/Conversionperiod xviii

Number of votingrights instrumentrefers to

% of voting rights xix, xx

 

Nominal

Delta

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

52,750,000

15.11%

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

 

Proxy Voting:

10. Name of the proxy holder:

11. Number of voting rights proxy holder will cease to hold:

12. Date on which proxy holder will cease to hold voting rights:

 

13. Additional information:

14. Contact name:

Jane Muir

15. Contact telephone number:

020 8819 6486

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLUGGAWGUPAGUP
Date   Source Headline
22nd Jun 20265:10 pmRNSTransaction in Own Shares and TVR
15th Jun 202612:25 pmRNSTransaction in Own Shares and TVR
12th Jun 20261:40 pmRNSNet Asset Value(s)
11th Jun 20262:27 pmRNSResult of AGM
9th Jun 202611:36 amRNSTransaction in Own Shares and TVR
8th Jun 20262:38 pmRNSTransaction in Own Shares and TVR
3rd Jun 20264:28 pmRNSTransaction in Own Shares and TVR
29th May 20262:33 pmRNSTransaction in Own Shares and TVR
22nd May 20265:19 pmRNSTransaction in Own Shares and TVR
18th May 20264:02 pmRNSDirector/PDMR Shareholding
18th May 20262:31 pmRNSAnnual Financial Report & Notice of AGM
15th May 20267:05 amRNSNet Asset Value(s)
15th May 20267:00 amRNSTransaction in Own Shares and TVR
12th May 20267:00 amRNSTransaction in Own Shares and TVR
11th May 202610:44 amRNSTransaction in Own Shares
8th May 20268:31 amRNSDirector/PDMR Shareholding
5th May 20262:29 pmRNSTransaction in Own Shares and TVR
1st May 20269:17 amRNSTransaction in Own Shares and TVR
29th Apr 20267:00 amRNSFinal Results
20th Apr 20261:17 pmRNSNet Asset Value(s)
16th Apr 20269:42 amRNSPortfolio Update: Animalcare Group Plc
24th Mar 20262:30 pmRNSTransaction in Own Shares and TVR
16th Mar 202611:29 amRNSNet Asset Value(s)
16th Mar 202611:13 amRNSTransaction in Own Shares and TVR
9th Mar 20261:14 pmRNSTransaction in Own Shares and TVR
2nd Mar 20264:22 pmRNSTransaction in Own Shares and TVR
27th Feb 20267:00 amRNSNotice of Investor Presentation
24th Feb 20263:57 pmRNSDirector/PDMR Shareholding
19th Feb 20265:13 pmRNSTransaction in Own Shares and TVR
19th Feb 202610:25 amRNSNet Asset Value(s)
18th Feb 20267:00 amRNSDividend Declaration
16th Feb 20263:18 pmRNSTransaction in Own Shares and TVR
13th Feb 20263:13 pmRNSHolding(s) in Company
12th Feb 20269:48 amRNSTransaction in Own Shares and TVR
9th Feb 20265:55 pmRNSTransaction in Own Shares and TVR
9th Feb 20269:15 amRNSTransaction in Own Shares and TVR
21st Jan 202612:52 pmRNSTransaction in Own Shares and TVR
19th Jan 202611:53 amRNSNet Asset Value(s)
19th Dec 20259:37 amRNSTransaction in Own Shares and TVR
15th Dec 20251:05 pmRNSNet Asset Value(s)
12th Dec 20258:59 amRNSTransaction in Own Shares and TVR
8th Dec 202511:35 amRNSTransaction in Own Shares and TVR
26th Nov 20259:38 amRNSTransaction in Own Shares and TVR
25th Nov 20259:44 amRNSTransaction in Own Shares and TVR
18th Nov 202510:34 amRNSNet Asset Value(s)
17th Nov 202510:21 amRNSTransaction in Own Shares and TVR
4th Nov 20253:51 pmRNSTransaction in Own Shares and TVR
3rd Nov 20259:29 amRNSTransaction in Own Shares and TVR
15th Oct 20253:58 pmRNSNet Asset Value(s)
9th Oct 20259:59 amRNSTransaction in Own Shares and TVR

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.